500th Newsletter

A Major Milestone for HealthEconomics.Com: A Letter from Dr. Peeples to Our Readers

Posted on May 4, 2020 by Patti Peeples, R.Ph., Ph.D.

Few health economists have the mission to create a globally recognized website of highly curated resources for health economics and outcomes research. Neither did I. But, as the unattributed English proverb states, “Necessity is the mother of invention”. Continue Reading →

500th Newsletter, HealthEconomics.Com 500th Newsletter, HealthEconomics.Com

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Search for:

Please leave this field empty

First name

Last name

Email Address *

Check your inbox or spam folder to confirm your subscription.

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

HealthEconomics.Com | A Scientist.com Company @www_healthecon ·

Inflation Reduction Act Could’ve Saved Medicare Billions from 2018 to 20203

http://ow.ly/L7ix50MHlHq

#HEOR #DrugPrices #DrugPricing #Medicare #Healthcare

Reply on Twitter 1620938845641400323 Retweet on Twitter 1620938845641400323 Like on Twitter 1620938845641400323 Twitter 1620938845641400323

HealthEconomics.Com | A Scientist.com Company @www_healthecon ·

Examining the Impact of Real-World Evidence in EMA Regulatory Decisions

http://ow.ly/wYHY50MHljo

#HEOR #RWE #RWD #HTA #EMA

Reply on Twitter 1620923171862888449 Retweet on Twitter 1620923171862888449 Like on Twitter 1620923171862888449 Twitter 1620923171862888449

HealthEconomics.Com | A Scientist.com Company @www_healthecon ·

10h

Savings From Humira Biosimilars May Take Some Time to Kick In

http://ow.ly/Wxw550MHiGp

#HEOR #Biosimilars #Therapeutics #DrugPrices #DrugPricing

Reply on Twitter 1620904160207032320 Retweet on Twitter 1620904160207032320 Like on Twitter 1620904160207032320 Twitter 1620904160207032320